The In3 project aims to drive the synergistic development and utilisation of in vitro and in silico tools for human chemical and nanomaterial safety assessment. The project focuses on the differentiation of human-induced Pluripotent Stem Cells (hiPSC) to toxicologically relevant target tissues (e.g., brain, lung, liver and kidney). The data and prediction tools generated will be used to develop safety assessment approaches that combine cheminformatics, mechanistic toxicology and biokinetics into computational models. Deployed all over Europe, the 15 PhD students involved in in3 are working closely together to coordinate their different projects, each of which is a step towards a safer world.

Edelweiss Connect is hosting Pranika Singh, responsible for data management and bioinformatics for the entire in3 project. Embedded at Edelweiss Connect’s main office in Technology Park Basel, she says, “My role in the project is to manage, integrate and analyse the existing data with the project data in order to make it available for modelling and bioinformatics workflow.”

Find more about this project in the following website: https://estiv.org/in3/index.php